BioCentury
ARTICLE | Clinical News

Dyax preclinical data

March 4, 2013 8:00 AM UTC

In rats, subcutaneous DX-2930 reduced carrageenan-induced paw edema vs. vehicle-treated controls. In non-human primates, the half-life of DX-2930 was 12.5 days. Data were presented at the American Aca...